Physician profile
Robert Causey
NPI 1033180963
$597.76
in general payments reported to CMS, 2019-2025
11 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.45 · 2021: $44.94 · 2022: $19.82 · 2023: $181 · 2024: $154 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $434 · Long Term Medical Supply Or Device Loan: $35.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.88 |
| Long Term Medical Supply Or Device Loan | $35.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $138.44 | 2021-2025 | Freestyle Libre |
| Astrazeneca Pharmaceuticals Lp | $111.70 | 2019-2025 | Airsupra, Breztri |
| Novo Nordisk INC | $95.43 | 2021-2025 | Rybelsus, Ozempic |
| Dexcom, INC. | $92.62 | 2022-2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $41.84 | 2023-2024 | Trelegy Ellipta |
| Baxter Healthcare | $35.67 | 2025 | Hillrom - Spot Vision Screener |
| Lilly USA, LLC | $29.72 | 2023 | Mounjaro, Trulicity |
| Amgen INC. | $18.11 | 2024 | Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $12.27 | 2019 | |
| Boston Scientific Corporation | $11.06 | 2019 | |
| Mylan Specialty L.P. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Causey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.